Article Versions Notes

Wei CH, Wang EW, Ma L, Zhou Y, Zheng L, Hampel H, Shehayeb S, Lee S, Cohen J, Kohut A, et al. POLD1 DEDD Motif Mutation Confers Hypermutation in Endometrial Cancer and Durable Response to Pembrolizumab. Cancers. 2023; 15(23):5674. https://doi.org/10.3390/cancers15235674

Wei, Christina Hsiao, Edward Wenge Wang, Lingzi Ma, Yajing Zhou, Li Zheng, Heather Hampel, Susan Shehayeb, Stephen Lee, Joshua Cohen, Adrian Kohut, and et al. 2023. "POLD1 DEDD Motif Mutation Confers Hypermutation in Endometrial Cancer and Durable Response to Pembrolizumab" Cancers 15, no. 23: 5674. https://doi.org/10.3390/cancers15235674

Wei, C. H., Wang, E. W., Ma, L., Zhou, Y., Zheng, L., Hampel, H., Shehayeb, S., Lee, S., Cohen, J., Kohut, A., Fan, F., Rosen, S., Wu, X., Shen, B., & Zhao, Y. (2023). POLD1 DEDD Motif Mutation Confers Hypermutation in Endometrial Cancer and Durable Response to Pembrolizumab. Cancers, 15(23), 5674. https://doi.org/10.3390/cancers15235674